Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tepha raises $4.3m for biomaterial development:

This article was originally published in Clinica

Executive Summary

Tepha, a private developer of medical devices used in surgical repair and regenerative medicine, has secured $4.3m in financing from The Vertical Group, Integra Ventures and Novartis Venture Fund. The Cambridge, Massachusetts-based company says it will use the proceeds to complete FDA 510(k) filings for its debut range of TephaFLEX products. TephaFLEX, a polyester biomaterial made from a natural metabolite and which degrades "in a cell-friendly manner", is currently being developed by Tepha for several applications including suture, surgical mesh and patch products, tissue repair and tissue engineered cardiovascular devices.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts